NCT06512584View on ClinicalTrials.gov

Efficacy and Safety of PJ009 in Patients with Short Bowel Syndrome Requiring Parenteral Nutrition

PHASE3RecruitingINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

September 3, 2024

Primary Completion Date

March 30, 2026

Study Completion Date

April 27, 2026

Conditions
Short Bowel Syndrome
Interventions
DRUG

PJ009

subcutaneous injections, 0.05 mg/kg once daily

DRUG

PJ009 Placebo

subcutaneous injections, once daily

Trial Locations (8)

102218

NOT_YET_RECRUITING

Beijing Tsinghua Changgung Hospital, Beijing

200072

NOT_YET_RECRUITING

Shanghai Tenth People's Hospital, Shanghai

210016

RECRUITING

General Hospital of Eastern Theater Command, Nanjing

266000

NOT_YET_RECRUITING

The Affiliated Hospital of Qingdao University, Qingdao

401147

NOT_YET_RECRUITING

Chongqing General Hospital, Chongqing

410013

NOT_YET_RECRUITING

The Third Xiangya Hospital of Central South University, Changsha

510655

NOT_YET_RECRUITING

The Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou

710061

NOT_YET_RECRUITING

The First Affiliated Hospital of Xi'an Jiaotong University, Xi’an

All Listed Sponsors
lead

Chongqing Peg-Bio Biopharm Co., Ltd.

INDUSTRY